Status:
UNKNOWN
Kumasi Cohort Study
Lead Sponsor:
Bernhard Nocht Institute for Tropical Medicine
Collaborating Sponsors:
Kwame Nkrumah University of Science and Technology
Kumasi Centre for Collaborative Research (KCCR)
Conditions:
HIV
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The main objective is to access efficacy of first and second line antiretroviral therapy (ART) and its determinants in patients treated at the Komfo Anokye Teaching Hospital in Kumasi (KATH), Ghana, a...
Detailed Description
Study design: Open randomized study Recruitment: All patients being on stable ART for at least one year will be asked to participate in the study after thorough information about the objectives/pro...
Eligibility Criteria
Inclusion
- able and willing to give informed written consent
- age \> 18 years
- on first line ART since \> 12 months
Exclusion
- not willing or able to comply with study procedures
Key Trial Info
Start Date :
June 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 28 2021
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT01853657
Start Date
June 1 2012
End Date
July 28 2021
Last Update
July 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Komfo Anokye Teaching Hospital
Kumasi, Ghana